Next-generation steel and metal alloys are a step closer to reality, thanks to an international research project involving a University of Queensland scientist. The work could overcome the problem of hydrogen alloy embrittlement that has led to catastrophic failures in major engineering and ... more
Stem cell identity unmasked by single cell sequencing technology
Scientists from The University of Queensland's Diamantina Institute have revealed the difference between a stem cell and other blood vessel cells using gene-sequencing technology.
Leading skin cancer and stem cell researcher Professor Kiarash Khosrotehrani said the findings provided evidence of how stem cells express genes that allow them to be identified within a blood vessel.
"Until now, we couldn't accurately say how a stem cell differed from the other cells without preconceived ideas," Professor Khosrotehrani said.
"We hypothesised that stem cells expressed genes that could separate them from other cells inside the blood vessel."
UQDI Senior Lecturer Dr Jatin Patel performed the study and looked at every single cell in the largest artery, the aorta, and identified the genes expressed by each cell through sequencing.
"This allowed us to examine every cell without any bias or pre-conceived idea of whether it is a stem cell or not," Dr Patel said.
The study used single-cell RNA sequencing to look at the gene expression of each cell and group common cells together into separate populations.
UQ Institute for Molecular Bioscience Senior Research Officer Dr Sam Lukowski performed the analysis.
"We used specialised algorithms to group cells that express similar sets of genes into clusters," Dr Lukowski explained.
"What we found is that these stem cells form little groups within the blood vessel and that is how you differentiate them from other cells."
Knowing the exact profile of a stem cell will help researchers develop new treatment options for conditions like skin cancer, heart attacks and wound healing.
"This will have an impact on how we treat conditions which are the result of dysfunctional blood vessel behaviour," Professor Khosrotehrani said.
"We know that if you can target these stem cells, then you can reduce blood vessel formation and potentially stop diseases like skin cancer metastasis."
Previous research by Professor Khosrotehrani found that stopping the spread of melanoma to other parts of the body might be as simple as cutting off the blood supply to cancer.
"Blood vessels are vital because tumours can't grow without them - they feed the tumours and allow the cancer to spread," he said.
"If you get rid of these stem cells, then the blood vessels don't form, and the tumours don't grow or spread to other locations."
In situations where blood vessels are missing or are clogged, providing more stem cells might generate new blood vessels and allow the supply of oxygen in cardiovascular diseases such as heart attacks, stroke or leg ischemia.
Professor Khosrotehrani had hypothesised this method of stem cell identification and said these findings provided answers to scientific debate.
"We've been working on this type of research for over ten years and the model we've found matches perfectly with our previous findings," he said.
"The availability of the data publicly will allow scientists from all over the world to hopefully end some of the controversy around the identity and definition of these stem cells."
- stem cells
- blood vessel cells
- gene sequencing
Researchers at the Universities of Queensland and New South Wales in Australia have discovered that the ability of a plastic to conduct electricity can be tuned by exposure to an ion beam. Usually plastics conduct electricity so poorly that they are used as the insulation around electrical ... more
In an important first for a promising new technology, scientists have used a quantum computer to calculate the precise energy of molecular hydrogen. This groundbreaking approach to molecular simulations could have profound implications not just for quantum chemistry, but also for a range of ... more
- 1Virtual screening for active substances against the coronavirus
- 2analytica 2020 is postponed
- 3Thermo Fisher Scientific to Acquire QIAGEN
- 4Smartphone lab finds coronavirus in saliva
- 5The digital laboratory live and tangible
- 6Roche’s cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization
- 7FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing
- 8analytica 2020: Bioanalysis for personalized medicine
- 9Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus
- 10New membrane separates small organic molecules